Teleflex Inc (TFX)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
- Symbol
- TFX
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Market cap
- $5.44B
- 52 week range
- 100.18 - 145
Valuation
- Share price
- $121.75 (close of 2026-09-23)
- P/E (TTM)
- -5.37x
- Price to book
- 1.87x
- Price to free cash flow
- 32.31x
- Enterprise value
- $8.01B
- Book value per share
- $66.68
Price performance
| Period | Change |
|---|
| 1 day | -2.44% |
| 5 days | -5.63% |
| 1 month | -12.30% |
| 3 months | -2.02% |
| 6 months | +15.02% |
| Year to date | -0.24% |
| 1 year | -0.29% |
| 3 years | -40.32% |
| 5 years | -68.72% |
| 10 years | -29.03% |
| All time | +7857.52% |
Profitability and growth
- Return on equity
- -28.98%
- Return on invested capital
- 2.16%
- Return on assets
- -13.04%
- Return on capital employed
- 1.91%
- Gross margin
- 56.24%
- Net margin
- -45.45%
- EBITDA margin
- 14.86%
- Revenue growth
- 17.25%
- Net income growth
- -1399.81%
- Free cash flow growth
- -99.32%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 3.10%
- Current ratio
- 2.60x
- Net debt to EBITDA
- 14.76x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $1.99B
- Cost of revenue
- $871.96M
- Gross profit
- $1.12B
- EBITDA
- $296.11M
- Net income
- $-905.64M
- Earnings per share
- $-20.30
- Research and development
- $144.78M
- Shares outstanding
- 44.62M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $1.99B | $1.12B | $-905.64M | $-20.30 |
| 2024-12-31 | $1.70B | $1.04B | $69.67M | $1.49 |
| 2023-12-31 | $1.71B | $1.04B | $356.33M | $7.58 |
| 2022-12-31 | $2.79B | $1.53B | $363.14M | $7.74 |
| 2021-12-31 | $2.81B | $1.55B | $485.37M | $10.38 |
| 2020-12-31 | $2.54B | $1.32B | $335.32M | $7.21 |
| 2019-12-31 | $2.60B | $1.41B | $461.47M | $9.99 |
| 2018-12-31 | $2.45B | $1.30B | $200.80M | $4.39 |
| 2017-12-31 | $2.15B | $1.17B | $152.53M | $3.39 |
| 2016-12-31 | $1.87B | $996.20M | $237.38M | $5.48 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | 56.24% | -45.45% | -28.98% | 2.16% |
| 2024-12-31 | 61.04% | 4.10% | 1.63% | 1.80% |
| 2023-12-31 | 60.74% | 20.81% | 8.02% | 3.53% |
| 2022-12-31 | 54.86% | 13.01% | 9.03% | 7.49% |
| 2021-12-31 | 55.15% | 17.28% | 12.93% | 10.50% |
| 2020-12-31 | 52.22% | 13.22% | 10.05% | 7.26% |
| 2019-12-31 | 54.29% | 17.78% | 15.49% | 9.11% |
| 2018-12-31 | 53.21% | 8.20% | 7.91% | 6.88% |
| 2017-12-31 | 54.60% | 7.11% | 6.28% | 5.58% |
| 2016-12-31 | 53.33% | 12.71% | 11.11% | 11.85% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $378.56M | $2.54B |
| 2024-12-31 | $247.85M | $1.56B |
| 2023-12-31 | $222.85M | $1.73B |
| 2022-12-31 | $292.03M | $1.62B |
| 2021-12-31 | $445.08M | $1.74B |
| 2020-12-31 | $375.88M | $2.38B |
| 2019-12-31 | $301.08M | $1.86B |
| 2018-12-31 | $357.16M | $2.07B |
| 2017-12-31 | $333.56M | $2.16B |
| 2016-12-31 | $543.79M | $850.25M |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $1.45M | $25.70M |
| 2024-12-31 | $211.44M | $25.96M |
| 2023-12-31 | $159.72M | $27.30M |
| 2022-12-31 | $263.62M | $27.22M |
| 2021-12-31 | $580.52M | $22.94M |
| 2020-12-31 | $346.45M | $20.74M |
| 2019-12-31 | $334.37M | $26.94M |
| 2018-12-31 | $354.29M | $22.44M |
| 2017-12-31 | $355.40M | $19.41M |
| 2016-12-31 | $357.45M | $16.87M |
Dividend history
- Most recent payment
- 2026-08-14
- Paid in the last twelve months
- $1.36
| Payment date | Dividend per share |
|---|
| 2026-08-14 | $0.34 |
| 2026-05-22 | $0.34 |
| 2026-03-06 | $0.34 |
| 2025-11-14 | $0.34 |
| 2025-08-15 | $0.34 |
| 2025-05-20 | $0.34 |
| 2025-03-07 | $0.34 |
| 2024-11-15 | $0.34 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-05
- Consensus EPS estimate
- $1.92
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-06 | Jun/2026 | $1.28 |
| 2026-05-07 | - | - |
| 2026-02-26 | - | - |
| 2025-11-06 | - | - |
| 2025-07-31 | - | - |
| 2025-05-01 | - | - |
| 2025-02-27 | - | - |
| 2024-10-31 | - | - |
Filings and sources
- Company website
- teleflex.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Intuitive Surgical Inc (ISRG) · Becton Dickinson & Co (BDX) · ResMed Inc (RMD) · West Pharmaceutical Services Inc (WST) · Baxter International Inc (BAX) · Align Technology Inc (ALGN) · Cooper Companies, Inc. (COO) · Vertex Pharmaceuticals Inc (VRTX)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades